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Since domestication, pigs have been used extensively in agriculture and kept as
companion animals. More recently they have been used in biomedical research,
given they share many physiological and anatomical similarities with humans. Recent
technological advances in assisted reproduction, somatic cell cloning, stem cell culture,
genome editing, and transgenesis now enable the creation of unique porcine models of
human diseases. Here, we highlight the potential applications and advantages of using
pigs, particularly minipigs, as indispensable large animal models in fundamental and
clinical research, including the development of therapeutics for inherited and chronic
disorders, and cancers.
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Introduction
The ﬁrst evidence of swine domestication dates back to approximately 7000–9000 years ago (Jones,
1998; McGlone and Pond, 2003; Köhn, 2011; Larson et al., 2011; Figure 1A). China and Europe
have been, since domestication, the pig-breeding centers dictating the proﬁle of the pig breeds
(Jones, 1998; Amills et al., 2001). The reason for domestication was to provide meat as a source
of food protein, which stimulated pig selection and farming (Jones, 1998; Köhn, 2011). Studies
have been conducted using genome-wide genotyping and genetic variability to trace the migration,
selection, and improvement from ancient wild species to modern swine (Giuﬀra et al., 2000; Bosse
et al., 2014a,b). It is generally accepted that the majority of all modern breeds are derived from the
Eurasian wild boar (European and Asian wild boars; Porter, 1993; Bosse et al., 2014b). Although
pig selection started just after domestication, it has only been since the mid-20th century that
performance has been used as the main tool in the animal selection process (Safranski, 2008). More
recently, molecular biology technologies, genome-wide association studies, and next-generation
sequencing have been applied to enhance the selection process of domesticated pig breeds (e.g.,
Duroc, Landrace, Pietrain, Yorkshire, etc.) to further improve traits of high economic value such
as feed conversion, meat quality, growth, precocious puberty, and proliﬁcity (Sahana et al., 2013;
Tart et al., 2013; Jiang et al., 2014; Sanchez et al., 2014).
The variety of modern pig breeds available today (Buchanan and Stalder, 2011), are a product
of human intervention since domestication, but especially during the last century (Figure 1A).
Besides breeds specialized for food production, smaller sized breeds (miniature- and micro-pigs)
with certain characteristics such as obedience, friendly nature, and cognitive ability have also been
selected for the purpose of companion animals. In addition, their use in biomedical research has
been increasing considerably in the last years (Figure 1B).
Compared with other animals used in research (e.g., mice, rats, rabbits, and dogs), domestic
farm pigs are much larger (>300 kg adult size), therefore, requiring more space and feed, and
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FIGURE 1 | History of pigs in agriculture and research since domestication. (A) Timeline, significant events and application of different technologies in the
selection and breeding of the porcine species (Jones, 1998; Onishi et al., 2000; Polejaeva et al., 2000; McGlone and Pond, 2003; Brevini et al., 2007a,b; Estrada
et al., 2008; Safranski, 2008; Wakai et al., 2008; Esteban et al., 2009; Ezashi et al., 2009; Hauschild et al., 2011; Köhn, 2011; Larson et al., 2011; Carlson et al.,
2012; Hai et al., 2014; Whitworth et al., 2014). (B) Use of the porcine species in research, and (C) application of minipig models in a variety of studies (based on
articles indexed by PubMed, from 1970 to the present date).
making them harder to handle. Mini- or micro-pigs are hence
more desirable for research use. The adult sizes vary among
breeds, reaching around 20–30 kg for a Panepinto micropig to
100 kg for a Munich minipig (Köhn, 2011). Although many
minipig breeds are a product of crossbreeding, some breeds, like
the Yucatan pigs, are naturally occurring stocks (Panepinto, 1996;
Köhn, 2011). Since the late 1940s, minipigs have been further
developed speciﬁcally for biomedical research purposes (England
and Panepinto, 1986; Köhn, 2011).
There are now several minipig breeds available for use in
research (Panepinto, 1996). The main breeds developed in
the USA are Yucatan, Sinclair (also known as Minnesota or
Hormel miniature pig), Hanford, NIH minipig and Panepinto
miniature pig. The minipig breeds developed in Europe
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are Göttingen, Munich, Berlin, Mini-Lewe, Czech-Republic,
Vietnamese potbellied and Mini-Sib. In Asia, the breeds include
Ohmini, Clawn, Lee Sung, and Chinese minipigs. The Göttingen
and Yucatan breeds are the most commonly used minipigs
in research, although there is no apparent clear reason for
preference. Unlike the Yucatan, a natural breed, the Göttingen
minipig was developed speciﬁcally for research use. Other breeds
are used only by speciﬁc research groups, thus limiting their
widespread availability in research. Nevertheless, the interest in
the use of pigs in biomedical research has been rising over the last
40–45 years (Figure 1B).
Use of Pigs in Biomedical Research
Biomedical research is broad, spanning studies on underlying
disease mechanisms to the evaluation of safety and eﬀectiveness
of preventative measures, diagnostic tests, and therapies. Most
animal studies in recent times have used the murine species
due to their small size, fast reproductive cycles and short
lifespan. In addition, the availability of murine embryonic stem
cells, fully annotated genome, and facile tools for targeted
genetic manipulation have all contributed to the elucidation of
gene functions and disease pathophysiology. However, in many
cases, mouse models do not adequately represent features of
human disorders (Seok et al., 2013). In this regard, animals
that better represent human pathophysiology are required. Pigs
and humans share many similarities such as size, physiology,
anatomy, metabolic proﬁle, and longer lifespan (Panepinto,
1996; Spurlock and Gabler, 2008; Kuzmuk and Schook, 2011;
Swindle et al., 2012). For example, pig skin is structurally similar
to human skin regarding thickness and spacing between hair
follicles, making it useful for studies on wound healing and
burn lesions (Sullivan et al., 2001). Pigs also share anatomical
and physiological similarities with respect to the renal system,
making them valuable for pharmacological studies (Dalgaard,
2014; Huppertz et al., 2015). Pigs can also be useful in the study
of nutrient absorption and intestinal transport, as well as the
pathogenesis of gastrointestinal diseases (Sangild et al., 2014). All
these characteristics contribute to the development of superior
models of human conditions (Kuzmuk and Schook, 2011).
The choice between outbred or inbred strains can have
a signiﬁcant impact on research outcomes (Festing, 2014).
While, outbred strains may be better suited for quantitative
trait loci studies, experiments addressing mechanistic aspects
would beneﬁt from the use of inbred strains (Chia et al.,
2005). Some minipig breeds are already established for speciﬁc
applications due to their unique characteristics (Table 1). Pigs
have also been used for testing new therapies, devices, and
eﬃcacy and safety of new drugs prior to human trials. For
instance, a novel endovascular chemotherapy ﬁlter, designed to
reduce circulatory drug excess in vitro, was successfully tested
in pigs (Patel et al., 2014). As well, a new method for pediatric
liver transplantation was validated using pigs (Leal et al., 2015).
Regarding pharmacokinetic and cytotoxic tests, pigs have been
used for testing topical skin formulations (Mitra et al., 2015),
and are considered a better choice compared to dogs for the
study of drugs that are metabolized by the aldehyde oxidase
(AOX1), N-acetyltransferase (NAT1 or NAT2) or cytochrome
(CYP2C9-like) enzymes (Dalgaard, 2014).
In general, there is low incidence of naturally occurring
pathologies described in pigs. The reason for this is twofold. First,
human intervention by way of selective breeding has eliminated
genes that increased disease susceptibility. Second, the majority
of the domestic farm pigs are slaughtered at a young age (<
6months old), precluding the detection of late onset diseases such
as cancer. On the other hand, Vietnamese potbellied minipigs
raised as companion animals do reach old ages. Indeed, a
retrospective study found a variety of neoplasms with widespread
metastases in these pigs of advanced age (∼11 years; Newman
and Rohrbach, 2012). The most common malignances found
included hepatic and intestinal carcinomas, and uterine and
ovarian smooth muscle tumors (Newman and Rohrbach, 2012).
Occurrence of malignant spontaneously regressing
melanomas has been described in Sinclair minipigs (Millikan
et al., 1974; Oxenhandler et al., 1979). Selective interbreeding,
by removing animals with red coat color that do not develop
the lesions, increased the frequency of tumor formation in
these selected minipigs (Millikan et al., 1974). The tumors
appear from birth and culminate in skin depigmentation after
tumor regression showing a phenotype similar to human vitiligo
(Millikan et al., 1974). Studies conducted in these minipigs
have shown decreased telomerase activity during melanoma
regression (Pathak et al., 2000), which has also been observed
by inhibiting telomerase activity in human melanoma cells
(Burchett et al., 2014). Therefore, these minipigs may represent
a useful model to study malignant melanomas because the
tumors appear spontaneously and then either regress or grow
progressively and metastasize similarly to human melanomas
(Oxenhandler et al., 1979).
Another example of a naturally occurring condition in pigs is
the dwarf phenotype, caused by a single amino acid change in the
α1 chain of type X collagen (Nielsen et al., 2000). The COL10A1
gene, which encodes type X collagen, is expressed in hypertrophic
chondrocytes during endochondral ossiﬁcation. In humans, an
amino acid variation in the same position of the type X collagen
protein has been shown to be the cause of Schmid metaphyseal
chondrodysplasia (SMCD), a mild skeletal disorder associated
with dwarﬁsm (Warman et al., 1993). Since mice lacking type X
collagen do not develop abnormalities in long bone development
(Rosati et al., 1994), pigs represent a better animal model of
human SMCD.
Another naturally occurring disease observed in Yucatan
minipigs mimics human ventricular septal defect (VSD; Swindle
et al., 1990). The VSD in pigs can be observed in fetal stages
similar to the congenital anomaly in humans, and can be used
for the study of new methods of diagnosis or therapies (Swindle
et al., 1990; Amin et al., 2006).
Despite a number of natural occurring pig phenotypes that
resemble human diseases, for most of human pathologies it
is diﬃcult to ﬁnd representative animal models in nature.
Thus, manipulation of diet, use of drugs and/or surgeries
has been necessary to generate appropriate models. For
example, minipig models for Type I diabetes were induced
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TABLE 1 | Characteristics and applications of minipig breeds for the study of human conditions.
Parameter Yucatan Gottingen Hanford Sinclair/Minnesota
Adult body size (kg) 70–83 ∼45 80–95 55–70
Average litter size 6 6.5 6.7 7.2
Age to puberty (months) 4–6 3–5 4–6 4–6
Genetic background Purebred Outbred Outbred Outbred
Cloning somatic cell nuclear transfer
(SCNT; Estrada et al., 2008)
SCNT (Wakai et al., 2008) Information not available SCNT (Do et al., 2012)
Transgenics Homologous recombination
BRCA1 (breast cancer
susceptibility gene 1) –
gene knockout by rAAV –
model for breast cancer
(Luo et al., 2011, 2012)∗
Introduction of missense
mutation via rAAV – TP53
gene – cancer cells (Sieren
et al., 2014)
Introduction of nonsense
mutation via rAAV – SCN5A
gene – cardiac arrhythmia
(Park et al., 2015)
Homologous recombination
BRCA1 (breast cancer
susceptibility gene 1) –
gene knockout by rAAV –
model for breast cancer
(Luo et al., 2012)†
rAAV vectors encoding
GFP (Kornum et al., 2010)
Information not available ZFN – mono and biallelic
knockout pigs – CMAH
gene – xenoantigen
involved in the rejection
phenomenon (Kwon et al.,
2013)
TALEN – biallelic modified
pigs – RAG2 gene –
immune system (Lee et al.,
2014)
Applications Wound healing (Eggleston
et al., 2000)
Cardiovascular model for
ventricular septal defect
(VSD; Swindle et al., 1990)
Metabolic Disorder (Phillips
et al., 1982)
Toxicity Studies (Bollen and
Ellegaard, 1997; van Mierlo
et al., 2013)
Skin pharmacokinetics
tests (Mitra et al., 2015)
Metabolic Syndrome
(Johansen et al., 2001)
Neurodegenerative
disease – Parkinson Model
(Bjarkam et al., 2008)
Obesity (Christoffersen
et al., 2013)
Heart failure (Schuleri et al.,
2008)
Dermal studies – toxicology
(Leigh et al., 2012)
Wound healing (Reger
et al., 1999)
Surgery training (Purohit
et al., 1993)
Tests of new therapies in
tissue regeneration (Van
Dyke et al., 2015)
Oncology (malignant
spontaneously regression
melanoma; Oxenhandler
et al., 1979)
Dermatology – skin
depigmentation (Millikan
et al., 1974)
Models of human
alcoholism (Dexter et al.,
1976)
Pediatric hypothyroidism
(Tank et al., 2013)
∗The animals died 18 days after birth.
†Cloned animals were not yet born at the time of publication.
via administration of streptozotocin or alloxan to selectively
destroy insulin-producing cells (Phillips et al., 1980; Larsen
et al., 2002). High-energy diets in young minipigs lead to
the development of obesity and metabolic syndromes, with
increased visceral fat deposition, glucose intolerance, decreased
insulin sensitivity, and higher levels of blood cholesterol and
triglycerides, which progress to Type 2 Diabetes mellitus (Xi
et al., 2004; Neeb et al., 2010; Koopmans and Schuurman,
2015). Other chemicals have been used to induce cellular
dysregulation and damage in pigs including the administration of
N-nitrosodiethylamine to produce a liver cancer model (Li et al.,
2006).
Use of Engineered Pigs in Biomedical
Research
Genetically modiﬁed animals have been instrumental in
advancing our understanding of gene function and signiﬁcance
of inappropriate gene expression in metabolic malfunction in
mammals. Genome editing holds great promise in generating
these models, and has already permitted the rapid development
of new pig models of several human diseases (Rogers et al., 2008;
Prather et al., 2013; Hai et al., 2014; Dicks, 2015).
The cystic ﬁbrosis (CF) model is an example of genetically
engineered pigs created by targeted inactivation of the cystic
ﬁbrosis transmembrane conductance regulator (CFTR) gene
(Rogers et al., 2008). The resulting pigs exhibit clinical features
and disease progression consistent with those observed in CF
infants. In contrast, inactivation of the CFTR gene in mice did
not produce the comorbidities typically observed in human CF
patients (Snouwaert et al., 1992).
Advanced reproductive technologies, such as somatic cell
nuclear transfer (SCNT), can now be routinely applied to large
animal species, including minipigs. Minipigs of diﬀerent breeds
have been cloned from diﬀerent cell types, including genetically
modiﬁed cells (Estrada et al., 2008; Kurome et al., 2008; Wakai
et al., 2008; Zhao et al., 2009). In addition SCNT oﬀers the
possibility of creating isogenic and immunocompatible animals
from the same cell line. Importantly, models of severe disorders
can be generated from engineered cultured cells without the
need of breeding sick animals. The sequencing of the pig
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genome is another key development in the production of gene-
modiﬁed pigs in the post-genomic era (Schook et al., 2015a).
Genome editing techniques, including zinc ﬁnger nucleases
(ZFN), transcription activator-like eﬀector nucleases (TALEN),
and clustered, regularly interspaced, short palindromic repeats
(CRISPR) together with CRISPR associated (Cas) nucleases
(CRISPR/Cas), now allow the precise manipulation of gene
sequences in germ, embryonic and somatic cells (Hauschild et al.,
2011; Carlson et al., 2012; Cong et al., 2013; Hai et al., 2014;
Whitworth et al., 2014; Dicks, 2015). Among these methods,
the CRISPR/Cas9 system is emerging as the method of choice
because it permits gene editing to be accomplished in only one
step by injecting both the speciﬁc guide RNAs and endonuclease
into zygotes (Hai et al., 2014; Whitworth et al., 2014).
Another example of human disease that has the potential to
be studied in genetically engineered pigs is heart arrhythmias
(Park et al., 2015). Mutations in the SCN5A gene, which
encodes a subunit of the cardiac sodium channel Nav1.5
required for excitability and conduction in the myocardium,
were found in patients with Bruguda syndrome (Hedley et al.,
2009). SCN5AE558X/+ engineered Yucatan minipigs with reduced
expression of the sodium channel Nav1.5 have been created and
these animals exhibit conduction abnormalities and susceptibility
to ventricular arrhythmias (Park et al., 2015). There has also been
considerable interest in genetically modiﬁed pig strains suitable
for xenotransplantation. Most research into the development of
appropriate xenotransplantation strains focused on addressing
hyperacute rejection, which is initiated rapidly and involves
preformed natural human antibodies and the complement system
(Cooper et al., 2002). This has been possible by targeting cell
surface antigens such as α-1,3 galactosyltransferase (Miyagawa
et al., 2001; Lai et al., 2002; Phelps et al., 2003; Takahagi et al.,
2005) or complement regulatory proteins such as human decay
accelerating factor (Murakami et al., 2002). The pigs made
deﬁcient of α-1,3 galactosyltransferase have contributed to the
reduction of immunogenicity of donor tissue/organs (Phelps
et al., 2003). Transgenic pigs expressing antibodies against
cytotoxic T-cell lymphocyte antigen receptor, a cell-mediated
immune response suppressor, were also developed (Phelps et al.,
2009).
A pig model for the human familial adenomatous polyposis
was generated by inactivation of the adenomatous polyposis coli
(APC) gene (Flisikowska et al., 2012). Mice lacking the APC gene
exhibit non-metastatic neoplasias only in the small intestine (Su
et al., 1992). However, the pig model of colon and rectal cancer
reproduces the human features of the disease, which includes the
development of polyps spread along the whole large bowel in
young animals. A candidate gene for the development of breast
and ovarian cancer models is the breast cancer-associated gene
1 (BRCA1), which has been manipulated in both Yucatan and
Göttingen cells, but lines of modiﬁed minipigs remain to be
produced (Luo et al., 2011, 2012). The TP53 gene, which encodes
the tumor suppressor protein p53 and is the most commonly
observed suppressed gene in human tumors, was found to be
mutated in Li-Fraumeni patients having increased risk to develop
multiple types of cancers (Gonzalez et al., 2009). Suppression of
p53 in mesenchymal stem cells derived from pig bone marrow
exhibits chemoresistance in vitro (Leuchs et al., 2012). Mutation
of TP53 gene in Yucatan minipigs resulted in development of
lymphomas and osteogenic tumors (Sieren et al., 2014). More
recently, a new engineered pig strain termed “oncopig” was
developed, which promises inducible formation of a wide variety
of cancers that are potentially novel platforms for research and
therapeutics development (Schook et al., 2015b). These examples
illustrate the potential of genetically engineered pigs as robust
models for the study of human pathologies that are not well
represented in small laboratory animal species.
Improving the Usefulness of Pigs in
Biomedical Research
Rodents have been the choice animal model for basic research,
but are not always suitable for translational research due
to marked diﬀerences in size, lifespan as well as metabolic,
anatomical, and physiological discrepancies. On the other hand,
the pig is more closely related to humans in terms of these
parameters (Swindle et al., 2012) and, therefore, is better suited
for recapitulation of human diseases. Indeed, the use of the
pig in translational research is increasingly gaining acceptance
(Figure 1C). Dogs and non-human primates have traditionally
been used for this purpose, but rising ethical concerns have
reduced their favor and increased demand for alternatives
(Swindle et al., 2012). The number of peer-reviewed papers
describing the use of pigs as biomedical models has risen
eightfold over the past 30 years (Figure 1B). Already, the pig has
become well established in many areas of research and training.
For instance, in the past 20 years the pig has replaced the dog as
a model for surgical training and has also gained FDA approval
for the testing of surgical implantation devices intended for
human use (Swindle et al., 2012; Schook et al., 2015a). Minipig
models, which aremuch smaller in size compared to the domestic
farm breeds, oﬀer lower operating costs compared to other large
animal models and also reduce the concern of ethical acceptance
given the already widespread use of pigs in agriculture (Bollen
and Ellegaard, 1997; Swindle et al., 2012).
Pigs oﬀer many exciting applications, including stem cell
research, tissue engineering and xenotransplantation. Although
incredible advances in transgenic pigs harboring various
engineered alterations designed to minimize graft versus host
rejection (Lai et al., 2002; Phelps et al., 2003, 2009; Klose et al.,
2005; Takahagi et al., 2005; Hauschild et al., 2011; Petersen
et al., 2011; Jeong et al., 2013), much work remains to be
accomplished since multiple genes need to be manipulated
given the various types of tissue rejection reactions (Takahagi
et al., 2005; Whyte and Prather, 2011; Jeong et al., 2013).
Porcine induced pluripotent stem cells (iPSCs) have been
produced (Esteban et al., 2009) and chimeric pigs were
generated using iPSC (West et al., 2010, 2011). This is highly
relevant since study of porcine iPSCs have eventual human
applications (Esteban et al., 2009), such as cell-based therapies.
However, the mechanisms of cellular reprogramming, directed
cell diﬀerentiation and species-speciﬁc cell culture requirements
necessitate further investigation (Ezashi et al., 2012). The
Frontiers in Genetics | www.frontiersin.org 5 September 2015 | Volume 6 | Article 293
Gutierrez et al. Pigs in biomedical research
International Society for Stem Cell Research has indicated in
their guidelines for translational use that validationmust occur in
both small and large animal models (Aigner et al., 2010). Tissue
repair is another potential application of engineered pig models.
Cartilage tissue grafts have been created using chondrocytes
isolated from infant minipigs (Deponti et al., 2014), and
mandibular condyle grafts have been generated from Yucatan
minipig adipose-derivedmesenchymal stem cells (Abukawa et al.,
2003). There has also been successful regeneration of bone defects
using engineered bone graft tissues in minipig models (Gröger
et al., 2003). If custom donor transgenic minipig strains can be
created, this could open the doors to other engineered tissue
replacements for human uses. For example, the use of blastocyst
complementation and pluripotent stem cells has been applied
to direct the development of otherwise missing organs in pigs
(Matsunari et al., 2013). This has increased the hope that it may
one day be possible to create non-immunogenic donor organs in
pigs using human iPSCs (Matsunari et al., 2013; Feng et al., 2015).
Finally, similarities in the porcine and human immune system
have sparked interest in vaccine development and eﬃcacy testing
in pigs (Meurens et al., 2012).
The completion of the porcine genome project in 2012 has
further facilitated the use of pigs in research. Data from this
project has enabled the comparative analysis of genetic sequences
and development of the necessary tools to create and validate
targeted genetic alterations in the porcine genome (Gun and
Kues, 2014; Schook et al., 2015a). In addition, the development of
RNASeq technology has facilitated transcriptome analysis, which
further improves our ability to identify important targets related
to certain phenotypic traits (Ropka-Molik et al., 2014). Other
recent achievements in the pig include the use of inducible or
conditional systems to control transgene expression (Kues et al.,
2006; Klymiuk et al., 2012), and tissue-speciﬁc expression of the
Cre recombinase (Li et al., 2009; Luo et al., 2014). These advances
will ensure the continued development of various pig strains for
research, similar to what has already been accomplished in mice.
Summary
It is clear that the use of the pig as a biomedical model
is increasingly gaining approval due to physiopathological
similarities with humans. However, some obstacles remain
to be overcome in order to realize the full potential of the
porcine species in developing new diagnostic and therapeutic
approaches. Despite the sequencing of the porcine genome,
full annotation has yet to be completed. This is essential to
facilitate interrogation of the pig genome and investigation
of less characterized genes. Eﬀorts to develop a complete
porcine proteome map as well as epigenome map are
currently underway (Meurens et al., 2012; Schook et al.,
2015a). These databases are necessary to understand disease
pathogenesis (Meurens et al., 2012; Schook et al., 2015a).
Moreover, the availability of both inbred and outbred breeds
of minipigs extends the utility of these species as a viable
large animal model. Continuing reﬁnements and adaptation
of technologies for genome editing, cell/tissue-speciﬁc gene
targeting strategies, stem cells and somatic cell cloning will
further facilitate the creation of specialized pig strains for
biomedical research.
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